---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265449717.md"
description: "Bayer's third-quarter sales amounted to EUR 9.66 billion, estimated at EUR 9.79 billion"
datetime: "2025-11-12T06:31:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265449717.md)
  - [en](https://longbridge.com/en/news/265449717.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265449717.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/265449717.md) | [繁體中文](https://longbridge.com/zh-HK/news/265449717.md)


# 

In the third quarter, Bayer's sales amounted to €9.66 billion, estimated at €9.79 billion

### Related Stocks

- [Bayer Aktiengesellschaft (BAYZF.US)](https://longbridge.com/en/quote/BAYZF.US.md)

## Related News & Research

- [<![CDATA[Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock]]>](https://longbridge.com/en/news/280356353.md)
- [Bayer - AskBio announces completion of enrollment in phase 2 clinical trial of AB-1002](https://longbridge.com/en/news/281314240.md)
- [Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative | BAYRY Stock News](https://longbridge.com/en/news/280658062.md)
- [Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock](https://longbridge.com/en/news/280318062.md)
- [Bayer Secures Regulatory Nod for MRI Contrast Agent in Japan](https://longbridge.com/en/news/280112038.md)